ALINITY I ANTI-TPO
Mexico·Clase I·III. DIAGNOSTIC AGENTS·ABBOTT LABORATORIES DE MEXICO SA DE CV·Registered August 16, 2018ENSAYO PARA LA DETERMINACIÓN DE AUTOANTICUERPOS IGG ANTIPEROXIDASA TIROIDEA (ANTI-TPO).
ASSAY FOR THE DETERMINATION OF IGG ANTI-THYROID PEROXIDASE (ANTI-TPO) AUTOANTIBODIES.
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- ENSAYO PARA LA DETERMINACIÓN DE AUTOANTICUERPOS IGG ANTIPEROXIDASA TIROIDEA (ANTI-TPO).
- Trade Name (English)
- ASSAY FOR THE DETERMINATION OF IGG ANTI-THYROID PEROXIDASE (ANTI-TPO) AUTOANTIBODIES.
- Analysis ID
- 2029R2018 SSA
- Registration Date
- August 16, 2018
- Name (Spanish)
- ABBOTT LABORATORIES DE MEXICO SA DE CV
- Name (English)
- ABBOTT LABORATORIES DE MEXICO SA DE CV
Access comprehensive regulatory information for ALINITY I ANTI-TPO (ALINITY I ANTI-TPO) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 2029R2018 SSA and manufactured by ABBOTT LABORATORIES DE MEXICO SA DE CV. The device was registered on August 16, 2018.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.